Brief: Tcr2 Therapeutics Inc - Estimates Cash And Cash Equivalents And Investments Were About $228.0 Million As Of December 31, 2020
19/01/2021 11:29
Jan 19 (Reuters) - TCR2 Therapeutics Inc TCRR.O :
* TCR2 THERAPEUTICS INC - ESTIMATES CASH AND CASH
EQUIVALENTS AND
INVESTMENTS WERE ABOUT $228.0 MILLION AS OF DECEMBER 31, 2020
Source text for Eikon: [https://bit.ly/35RKxL2]
Further company coverage: TCRR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TCR2 Therapeutics
See all newsBrief: TCR2 Therapeutics Entered Into An Assignment Of Lease Agreement With Astrazeneca
TCR2 Therapeutics falls on bigger-than-expected Q1 loss
Brief: Tcr² Therapeutics Reports Q1 2023 Financial Results And Provides Corporate Update
TCR2 Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
TCR2 Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview